-+ 0.00%
-+ 0.00%
-+ 0.00%

BioCryst Pharma: Q4 Earnings Insights

Benzinga·02/26/2026 12:40:10
Listen to the news

BioCryst Pharma (NASDAQ:BCRX) announced its Q4 earnings on Thursday, February 26, 2026 at 07:00 AM.

Here's a breakdown of the earnings report.

Earnings

BioCryst Pharma missed estimated earnings by -21.43%, reporting an EPS of $0.055 versus an estimate of $0.07.

Revenue was up $31.75 million from the same period last year.

Past Earnings Performance

In the previous quarter, the company beat on EPS by $0.08, resulting in a 1.46% drop change in the share price the following day.

Here's a look at BioCryst Pharma's past performance:

Quarter Q3 2025 Q2 2025 Q1 2025 Q4 2024
EPS Estimate 0.08 0.03 -0.05 -0.06
EPS Actual 0.16 0.15 0 -0.13
Revenue Estimate 162.24M 149.43M 127.79M 130.05M
Revenue Actual 159.40M 163.35M 145.53M 131.53M

To track all earnings releases for BioCryst Pharma visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.